- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Placebo to interferon beta-1a
Total 3057 results
-
EMD SeronoPfizerCompletedMultiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Pregnancy | Prenatal Exposure Delayed EffectsUnited States
-
Faron Pharmaceuticals LtdTerminatedPreventive Medicine | Multi Organ FailureLithuania, Estonia, Finland
-
Louisiana State University Health Sciences Center...BiogenCompletedMultiple SclerosisUnited States
-
National Institute of Neurological Disorders and...Completed
-
EMD SeronoTerminatedMultiple SclerosisUnited States
-
Trio Medicines Ltd.BiogenCompleted
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
CelgeneCompletedRelapsing Multiple SclerosisSpain, United States, United Kingdom, Croatia, Serbia, Belarus, Hungary, Bulgaria, Poland, Italy, Ukraine, Greece, Belgium, Georgia, Bosnia and Herzegovina, Moldova, Republic of, Romania, Russian Federation, Slovakia, South Africa and more
-
BiogenCompletedMultiple SclerosisUnited States, Australia, Austria, Canada
-
Merck KGaA, Darmstadt, GermanyMerck Serono Middle East FZ LLCCompletedRelapsing Multiple Sclerosis (RMS)Bulgaria, Poland, Argentina, Hungary, Korea, Republic of, Saudi Arabia, Egypt, Algeria, Bahrain, Iran, Islamic Republic of, Kuwait, Lebanon, Morocco
-
Beth Israel Deaconess Medical CenterBiogenCompletedMultiple Sclerosis | Optic Neuritis | Transverse Myelitis | Acute Brainstem/Cerebellar SyndromeUnited States, Canada
-
BiocadCompletedHealthyRussian Federation
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisKorea, Republic of
-
BiogenCompletedMultiple SclerosisBelgium
-
University of California, San FranciscoOregon Health and Science University; National Multiple Sclerosis SocietyCompletedMultiple SclerosisUnited States
-
BayerNovartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe LtdCompleted
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
Saint Francis CareBiogenCompleted
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-Remitting
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.P.A., ItalyCompleted
-
Nancy Hammond, MDKansas City Area Life Sciences Institute, Inc.CompletedMultiple Sclerosis | Low Bone DensityUnited States
-
Merck KGaA, Darmstadt, GermanyMerck B.V., Netherlands; Merck A.E., Greece; Merck OY, Finland; Merck A.B., Sweden and other collaboratorsCompletedMultiple Sclerosis, Relapsing RemittingGreece
-
Emanuele BosiTerminatedCOVID-19 Virus InfectionItaly
-
National Institute of Allergy and Infectious Diseases...CompletedCOVID-19United States, Japan, Mexico, Singapore, Korea, Republic of
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
EMD SeronoTerminatedCrohn's DiseaseGermany, Italy, Sweden, Switzerland, United Kingdom
-
BiogenCompleted
-
Shahid Beheshti University of Medical SciencesUnknown
-
Merck KGaA, Darmstadt, GermanyCompleted
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
BiogenTerminatedRelapsing Remitting Multiple SclerosisAustralia
-
BiogenCompletedMultiple SclerosisUnited States
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A.S, FranceCompletedMultiple Sclerosis, Relapsing, Remitting
-
Revalesio CorporationWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.Withdrawn
-
BiogenRecruitingMultiple SclerosisSpain, Ireland, United States, Germany
-
Centre Hospitalier Universitaire VaudoisBioPartners GmbHCompletedMultiple Sclerosis, Relapsing-Remitting
-
BiogenActive, not recruitingRelapsing-Remitting Multiple SclerosisItaly, Belgium, United States, Hungary, Sweden, United Kingdom, Israel, France, Czechia, Poland, Serbia, Denmark, Spain, Turkey, Bulgaria, Germany, Canada, Kuwait
-
BiogenCompleted
-
BiogenWithdrawnRelapsing-Remitting Multiple Sclerosis (RRMS)
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
The University of The West IndiesUnknown
-
Holy Name Medical Center, Inc.BiogenUnknownMultiple SclerosisUnited States
-
Qassim UniversityUnknown
-
Eiger BioPharmaceuticalsActive, not recruitingHepatitis Delta VirusUnited States, France, Belgium, Spain, Italy, Turkey, Bulgaria, Germany, Israel, Romania, Georgia, Moldova, Republic of
-
Fred LublinNational Institute of Neurological Disorders and Stroke (NINDS)CompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
Aaron BosterPfizer; EMD SeronoCompleted
-
University of Turin, ItalyDimensione Ricerca s.r.l.CompletedMultiple Sclerosis